"Multiple Drug Reactions in a Patient with AIDS" CDC Daily UpdateImportant note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to CDC Daily Update main menu





DonateNow




"Multiple Drug Reactions in a Patient with AIDS"

Lancet (12/16/89) Vol. 2, No. 8677, P. 1455
Wignants, H., et al.


Abstract: Writing in response to a report by Drs. Ong and Mandal (Lancet, Oct. 21), H. Wignants and colleagues from the Institute of Tropical Medicine, Antwerp, Belgium, discuss the case of a 40-year-old gay man with HIV infection and Kaposi's sarcoma who displayed a hypersensitivity to several antibiotics. In June 1989, both co-trimoxazole and amoxycillin, taken to treat Salmonella typhimurium infection, caused a generalized rash. Later, after treatment with ofloxacin, the man developed a generalized maculopapular rash, at which time the doctors replaced oxfloxacin with chloramphenicol. After disappearing for a few days, the rash recurred and the patient developed Stevens-Johnson syndrome. Following the discontinuation of all tuberculostatic drugs, the fever disappeared and the mucotaneous lesions gradually healed. Megalumine ioxitalamate later caused a sustained rash with high fever. In four of 33 patients with AIDS, the researchers report, they have seen a drug reaction against at least two drugs.


891216
AD890035


Copyright © 1989 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.

.